Amgen(HK:4332)
HK$1,799.000.00 (0.00%)
HK:4332
Amgen financials statements
HK$1,799.00
At close:0.00 (0.00%)
Amgen (4332) Income Statement
0 Followers
Amgen Income Statement
Last quarter (Q3 2026), Amgen's total revenue was $10.37B, an increase of 8.45% from the same quarter last year. In Q3, Amgen's net income was $3.86B. See Amgen’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 36.74B | $ 33.42B | $ 28.19B | $ 26.32B | $ 25.98B | |
| $ 26.01B | $ 20.57B | $ 19.77B | $ 19.92B | $ 19.52B | |
| $ 16.93B | $ 13.31B | $ 11.84B | $ 10.35B | $ 11.89B | |
| Depreciation and Amortization | $ 5.17B | $ 5.59B | $ 4.07B | $ 3.42B | $ 3.40B |
| $ 16.90B | $ 13.36B | $ 14.80B | $ 12.17B | $ 11.30B | |
| $ 9.08B | $ 7.26B | $ 7.90B | $ 9.57B | $ 7.64B | |
| $ -104.00M | $ -2.65B | $ -42.00M | $ -2.22B | $ -938.00M | |
| $ 8.98B | $ 4.61B | $ 7.86B | $ 7.35B | $ 6.70B | |
| $ 7.71B | $ 4.09B | $ 6.72B | $ 6.55B | $ 5.89B | |
| Per Share Metrics | |||||
| Basic EPS | $ 14.33 | $ 7.62 | $ 12.56 | $ 12.18 | $ 10.34 |
| Diluted EPS | $ 14.23 | $ 7.56 | $ 12.49 | $ 12.11 | $ 10.28 |
| Weighted Average Shares Outstanding | 538.00M | 541.00M | 535.00M | 538.00M | 570.00M |
| Weighted Average Shares Outstanding (Diluted) | 542.00M | 541.00M | 538.00M | 541.00M | 573.00M |
Currency in USD

